Box score
Spine BioPharma, Inc.
Reported $13.5M sold in a new Form D filed December 18, 2024 (New York, New York).
- Biggest raise
- $13.5M filed Dec 18, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- New York, New York
- Season rank
- #301 of 1,389 in the Bio & Health League; #1493 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 2
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1852647.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Remunix, Inc. rookie | Bio & Health | $15.7M |
| 2 | Conceivable Life Sciences Inc. | Bio & Health | $15.1M |
| 3 | Salvo Health, Inc. rookie | Bio & Health | $15.1M |
| 4 | Volastra Therapeutics, Inc. | Bio & Health | $15M |
| 5 | Helicore Bioventures I, Inc. rookie | Bio & Health | $15M |
| 6 | IN8BIO, Inc. | Bio & Health | $12.4M |